In the present study, idelalisib induces PUMA expression through GSK-3β/NF-κB pathway following AKT inhibition and initiates apoptosis through the intrinsic apoptosis pathway in colon cancer cells. The gene discussed is NFKB1; the disease is malignant colon neoplasm.